AGC
CL icon

Aspen Grove Capital’s Colgate-Palmolive CL Stock Holding History

Aspen Grove Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-9,017
Closed -$695K – 182
2023
Q2 		$695K Buy
9,017
+1,120
+14% +$86.7K 0.22% 90
2023
Q1 		$593K Buy
7,897
+177
+2% +$13.2K 0.26% 77
2022
Q4 		$608K Buy
+7,720
New +$579K 0.28% 69

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Aspen Grove Capital's CL Position: Q3 2023 in Review

Aspen Grove Capital sold out of Colgate-Palmolive (CL) in Q3 2023, closing a stake of 9,017 shares — an estimated $695K sold.

Aspen Grove Capital first reported a position in CL in Q4 2022 and held it in 3 quarters. The position peaked at $695K in Q2 2023. 1,620 funds tracked by Wall St. Rank hold CL as of Q3 2023.

  • Aspen Grove Capital reported no remaining Colgate-Palmolive position as of Q3 2023 after selling out during the quarter.
  • Aspen Grove Capital sold 9,017 Colgate-Palmolive shares in Q3 2023, an estimated $695K.
  • Aspen Grove Capital first reported a position in Colgate-Palmolive in Q4 2022 and held it in 3 quarters.
  • Aspen Grove Capital's Colgate-Palmolive position peaked at $695K in Q2 2023.
  • 1,620 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2023.

Based on Aspen Grove Capital's 13F filing for Q3 2023, filed 13 Nov 2023.